Move to topTop

Keeping Our Founding Spirit for the Next 100 Years,
Pioneering the Future of Healthcare

Shinjiro Sato President and CEO

Shinjiro Sato
President and CEO

We express our deepest gratitude to all our shareholders for your understanding and support of Terumo Group business activities.

COVID-19 continues to rage in many areas of the world, and new variants are emerging as well. Although vaccination is gradually progressing in each country, the need continues to remain vigilant. We offer our deepest condolences for those who have lost their lives due to the pandemic, and our best wishes for the recovery of all who have been infected.

To enable opportunities for the most people to receive vaccination as soon as possible, Terumo enhanced the needle length of its FN Syringe, which is designed to leave minimal drug product in the vial, and began production in March 2021. We also fully launched its Infection Prevention Initiative, which coordinates Terumo toward providing new value in infection prevention measures to medical institutions. We will propose comprehensive solutions that address healthcare activities as a whole, to provide peace of mind and support to medical professionals and patients, through products they can use functionally to help prevent infections.

In addition, Terumo established a Japan Sales Department this fiscal year as part of its organizational transformation. "Project Scrum" had already led group-wide, cross-business efforts toward Japan growth, and this new organization takes these efforts to a new stage of growth acceleration. Amid COVID-19 last fiscal year, sales grew faster in Japan than in markets outside Japan, reaching 200 billion yen in sales revenue for the first time, to drive consolidated performance of the Terumo Group globally. One focus of the current Mid- to Long-term Growth Strategy is to return to the growth trajectory in the Japan market. The strategic foundation laid by each business to that end is now creating results. Terumo will continue to increase its presence in Japan, toward even stronger support for medical settings in the land of its founding.

On September 17, 2021, Terumo will celebrate the 100th Anniversary of its founding. One hundred years ago, as thermometer imports to Japan stopped due to World War I, Dr. Shibasaburo Kitasato and other doctors and scientists founded Terumo to meet the desperate need for production of high-quality thermometers in Japan. Throughout its journey since then, Terumo has been faithful to its Group Mission of Contributing to Society through Healthcare. Terumo will maintain that spirit for another 100 years as it pioneers the future of healthcare.

We ask for your continued understanding and support in this endeavor.

June 2021